|
|
|
|
|
|
|
|
|
|
Rv1908c More about Rv1908c on TBDB.org More about Rv1908c on TubercuList |
Display all mutations or select a bar from the histogram above to examine in greater detail |
| Rv1908c: Codons 300 to 319: 36 mutations (high confidence mutations are highlighted in yellow) | |||||||||||||||
| Primary reference | Polymorphism | Nucleotide position | Codon position | Amino acid | Time period | Origin | Molecular detection method | Gene coverage | Resistance pattern | MIC | Susceptibility testing method | R/Total isolates | R/S isolates with mutation | Additional mutations | High confidence support |
| Lee ASG AAC 1999 | TGG/TAA or TGG/TAG or TGG/TGA | - | 300 | Trp/STOP | 1994-1996 | Singapore | Sequencing | Whole gene | H | 0.1 ug/ml | BACTEC 460 | 160/192 | - | - | - |
| Marttila HJ AAC 1996 | TGG/GGG | 898 | 300 | Trp/Gly | 1989-1995 | Finland | Sequencing | Whole gene | H | 1 ug/ml | Disk elution method | 54/56 | 1/0 | - | - |
| Gagneux S PLOS Path 2006 | ins T | 901-902 | 301 | Frameshift | - | - | - | - | - | - | - | - | - | - | - |
| Cockerill FR JID 1995 | AGC/AGG | 906 | 302 | Ser/Arg | 1995 | USA | Sequencing | Whole gene | H | 8ug/ml | Proportion method | 40071 | 1/0 | Ser315Thr and Arg463Leu in katG. | - |
| Bolotin S JAC 2009 | TAT/TCT | 911 | 304 | Tyr/Ser | 1999-2001 | Canada | Sequencing | codon 250-500 | H, HR | - | MGIT 960 | 154/504 | 1/0 | - | - |
| Bostanabad SZ Tuberk Torak 2007 | GGC/GCC | 913 | 305 | Gly/Ala | 2004-2005 | Belarus | PCR, Sequencing. | 209-bp segment. | H | >1ug/ml | Proportion method, BACTEC | 42/42 | 3/0 | Most had 1-4 other katG mutations (most often in codon 315). | - |
| Bostanabad SZ Tuberk Torak 2007 | GGA/CGA | 919 | 307 | Gly/Arg | 2004-2005 | Belarus | PCR, Sequencing. | 209-bp segment. | H | >1ug/ml | Proportion method, BACTEC | 42/42 | 1/0 | Most had 1-4 other katG mutations (most often in codon 315). | - |
| Bostanabad SZ Tuberk Torak 2007 | GGA/GCA | 920 | 307 | Gly/Ala | 2004-2005 | Belarus | PCR, Sequencing. | 209-bp segment. | H | >1ug/ml | Proportion method, BACTEC | 42/42 | 2/0 | Most had 1-4 other katG mutations (most often in codon 315). | - |
| Ramaswamy SV J Med Micro 2004 | GGA/GAA | 920 | 307 | Gly/Glu | 1996-1998 | Mexico | Directed Oligonucleotide array, Sequencing | codon 228-357 | HRSE | >=1% growth 0.2ug/ml I, 40ug/ml R, 4ug/ml S, 2ug/ml E | Proportion method | 37/50 | 1/0 | Ser450Leu rpoB, | - |
| Khadka DK Southest Asian J Trop Med Public Health 2007 | ACC/CCC | 922 | 308 | Thr/Pro | 2007 | Bangkok | PCR-SSCP, Sequencing | 894 bp fragment encompassing codons 254 to 549 | HRSEO | - | - | 29/30 | 1/0 | Arg463Leu katG, C(-15)T inhA | - |
| Bostanabad SZ Tuberk Torak 2007 | GGT/GTT | 926 | 309 | Gly/Cys | 2004-2005 | Belarus | PCR, Sequencing. | 209-bp segment. | H | >1ug/ml | Proportion method, BACTEC | 42/42 | 2/0 | Most had 1-4 other katG mutations (most often in codon 315). | - |
| Bostanabad SZ Tuberk Torak 2007 | GGT/GCT | 926 | 309 | Gly/Ser | 2004-2005 | Belarus | PCR, Sequencing. | 209-bp segment. | H | >1ug/ml | Proportion method, BACTEC | 42/42 | 2/0 | Most had 1-4 other katG mutations (most often in codon 315). | - |
| Kim SY Diagn Micro Inf Dis 2003 | GGT/GAT | 926 | 309 | Gly/Asp | 200-2002 | South Korea | PCR-SSCP, Sequencing | 210 bp fragment spanning codon 315 | HR | 0.2 ug/ml I 40 ug/ml R | Proportion method | 71/97 | 2/0 | inhA Ribosomal binding site C/T | - |
| Bostanabad SZ Tuberk Torak 2007 | GGT/GTC | 926-927 | 309 | Gly/Phe | 2004-2005 | Belarus | PCR, Sequencing. | 209-bp segment. | H | >1ug/ml | Proportion method, BACTEC | 42/42 | 2/0 | Most had 1-4 other katG mutations (most often in codon 315). | - |
| Huang WL JCM 2009 | del A | 928-929 | 310 | Frameshift | 2007-2008 | Taiwan | Sequencing | N.S. | 242MDR | N.S. | MGIT 960 | 242/272 | 1/0 | not mentiond | - |
| Bostanabad SZ Tuberk Torak 2007 | GAC/TAC | 931 | 311 | Asp/Tyr | 2004-2005 | Belarus | PCR, Sequencing. | 209-bp segment. | H | >1ug/ml | Proportion method, BACTEC | 42/42 | 2/0 | Most had 1-4 other katG mutations (most often in codon 315). | - |
| Bostanabad SZ Tuberk Torak 2007 | GAC/TTC | 931-932 | 311 | Asp/Phe | 2004-2005 | Belarus | PCR, Sequencing. | 209-bp segment. | H | >1ug/ml | Proportion method, BACTEC | 42/42 | 2/0 | Most had 1-4 other katG mutations (most often in codon 315). | - |
| Chan RCY JAC 2007 | GAC/GGC | 932 | 311 | Asp/Gly | 2007 | Hong Kong | PCR-SSCP, Sequencing | 703 bp fragment | HEP | 1ug/ml I, 4ug/ml E, 100ug/ml P | Absolute concentration method, BACTEC MGIT 960 | 241/302 | 1/0 | 574Ser/Leu rpoB | - |
| Zenteno-Cuevas R MemInstOswaldCruz 2009 | GAC/GAG | 933 | 311 | Asp/Glu | 2007 | Mexico | Sequencing | codon 240-390 of katG | HREZ | N.S. | BACTEC 460 | 17/25 | 1/0 | katG S315T | - |
| Bostanabad SZ Tuberk Torak 2007 | ACC/AAC | 941 | 314 | Ser/Asn | 2004-2005 | Belarus | PCR, Sequencing. | 209-bp segment. | H | >1ug/ml | Proportion method, BACTEC | 42/42 | 2/0 | Most had 1-4 other katG mutations (most often in codon 315). | - |
| Bostanabad SZ Tuberk Torak 2007 | ACC/ACG | 941-942 | 314 | Ser/Thr | 2004-2005 | Belarus | PCR, Sequencing. | 209-bp segment. | H | >1ug/ml | Proportion method, BACTEC | 42/42 | 2/0 | Most had 1-4 other katG mutations (most often in codon 315). | - |
| Haas WA AAC 1997 | AGC/CGC | 943 | 315 | Ser/Arg | 1997 | South Africa | PCR-RFLP | 894 bp central fragment of katG? | H | - | - | 124/212 | 1/0 | - | - |
| Marttila HJ AAC 1996 | AGC/CTA | 943 | 315 | Ser/Leu | 1989-1995 | Finland | Sequencing | Whole gene | HS | >1ug/ml | Disk elution method. | 17/19 | 1/0 | katG Pro501Ala. | - |
| Secondary Publication: Ramaswamy S Musser JM Tubercle lung Dis 1998 | AGC/GGC | 943 | 315 | Ser/Gly | - | - | - | - | - | - | - | - | - | - | - |
| Musser JM JID 1996 | AGC/ACC | 944 | 315 | Ser/Thr | - | - | - | - | - | - | - | - | - | - | - |
| Haas WA AAC 1997 | AGC/ATC | 944 | 315 | Ser/Ile | 1997 | Sierra Leone, Lesotho | PCR-RFLP | 892 bp central fragment | HRSEth,H | - | - | 124/212 | 4/0 | - | ![]() |
| Haas WA AAC 1997 | AGC/AAC | 944 | 315 | Ser/Asn | 1997 | Free state, Gauteng, Sierra leone | PCR-RFLP | 890 bp fragment | H,HRE,HR | - | - | 124/212 | 9/0 | - | ![]() |
| Heym B MolMicro 1995 | AGC/ACC | 944 | 315 | Ser/Thr | 1995 | Mali Ivory coast, France | PCR-SSCP, Sequencing | Whole gene | H | 1 in 4 and >5 in 1 | Proportional method | 34/37 | 5/0 | - | ![]() |
| Marttila HJ AAC 1996 | AGC/ACA | 944-945 | 315 | Ser/Thr | 1989-1995 | Finland | Sequencing | Whole gene | HS,HRS | 1 ug/ml for I | Disk elution method. | 54/56 | 2/0 | nt1501G/C katG in one | ![]() |
| Gagneux S PLOS Path 2006 | AGC/ACG | 944-945 | 315 | Ser/Thr | - | - | - | - | - | - | - | - | - | - | - |
| Lipin MY CMI 2007 | AGC/AGA | 945 | 315 | Ser/Arg | 1998-2001 | Russia | Sequencing | nt 872-1568 | HRS | 1 ug/ml I, 5 ug/ml S, 20ug/ml R | Absolute concentration method | 217/217 | 2/0 | 335 /GTC katG in one | ![]() |
| Secondary Publication: Hazbon MH AAC 2006 | AGC/AGG | 945 | 315 | Ser/Arg | - | - | - | - | - | - | - | - | - | - | - |
| Bostanabad SZ Tuberk Torak 2007 | GGC/AGC | 946 | 316 | Gly/Ser | 2004-2005 | Belarus | PCR, Sequencing. | 209-bp segment. | H | >1ug/ml | Proportion method, BACTEC | 42/42 | 18/0 | Most had 1-4 other katG mutations (most often in codon 315). | - |
| Secondary Publication: Hazbon MH AAC 2006 | GGC/GAC | 947 | 316 | Gly/Asp | - | - | - | - | - | - | - | - | - | - | - |
| Chan RCY JAC 2007 | ATC/CTC | 949 | 317 | Ile/Leu | 1994-2004 | Hong Kong | PCR-SSCP, Sequencing | Whole gene | N.S. | - | Absolute concentration method | 250 | 241 | 2 | - |
| Zenteno-Cuevas R MemInstOswaldCruz 2009 | GAG/GTA | 953-954 | 318 | Gly/Val | 2007 | Mexico | Sequencing | codon 240-390 of katG | HRSEZ | N.S. | BACTEC 460 | 17/25 | 1/0 | katG S315T | - |
Disclaimer: These are all putative mutations found in drug resistant clinical TB isolates. No a priori decisions have been made as to whether these mutations are causally related to resistance or possible secondary mutations. |
|
© 2010 Andreas Sandgren | Supported by the Swedish Research Council | Contact Database Curator |